Logo image of CHKP

CHECK POINT SOFTWARE TECH (CHKP) Stock Fundamental Analysis

USA - NASDAQ:CHKP - IL0010824113 - Common Stock

196.62 USD
+0.08 (+0.04%)
Last: 9/18/2025, 2:37:41 PM
Fundamental Rating

7

Taking everything into account, CHKP scores 7 out of 10 in our fundamental rating. CHKP was compared to 280 industry peers in the Software industry. CHKP scores excellent points on both the profitability and health parts. This is a solid base for a good stock. CHKP has a correct valuation and a medium growth rate. These ratings could make CHKP a good candidate for quality investing.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

CHKP had positive earnings in the past year.
CHKP had a positive operating cash flow in the past year.
Each year in the past 5 years CHKP has been profitable.
CHKP had a positive operating cash flow in each of the past 5 years.
CHKP Yearly Net Income VS EBIT VS OCF VS FCFCHKP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

1.2 Ratios

CHKP's Return On Assets of 15.09% is amongst the best of the industry. CHKP outperforms 91.79% of its industry peers.
With an excellent Return On Equity value of 30.27%, CHKP belongs to the best of the industry, outperforming 92.50% of the companies in the same industry.
With an excellent Return On Invested Capital value of 19.22%, CHKP belongs to the best of the industry, outperforming 93.57% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for CHKP is significantly above the industry average of 11.85%.
Industry RankSector Rank
ROA 15.09%
ROE 30.27%
ROIC 19.22%
ROA(3y)14.46%
ROA(5y)14.34%
ROE(3y)29.1%
ROE(5y)27.36%
ROIC(3y)20.07%
ROIC(5y)19.43%
CHKP Yearly ROA, ROE, ROICCHKP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

CHKP has a better Profit Margin (32.48%) than 92.14% of its industry peers.
CHKP's Profit Margin has declined in the last couple of years.
The Operating Margin of CHKP (33.00%) is better than 94.29% of its industry peers.
In the last couple of years the Operating Margin of CHKP has declined.
CHKP has a better Gross Margin (86.92%) than 94.29% of its industry peers.
In the last couple of years the Gross Margin of CHKP has remained more or less at the same level.
Industry RankSector Rank
OM 33%
PM (TTM) 32.48%
GM 86.92%
OM growth 3Y-6.58%
OM growth 5Y-5.03%
PM growth 3Y-4.32%
PM growth 5Y-4.45%
GM growth 3Y-0.2%
GM growth 5Y-0.37%
CHKP Yearly Profit, Operating, Gross MarginsCHKP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

9

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), CHKP is creating value.
The number of shares outstanding for CHKP has been reduced compared to 1 year ago.
The number of shares outstanding for CHKP has been reduced compared to 5 years ago.
CHKP has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CHKP Yearly Shares OutstandingCHKP Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
CHKP Yearly Total Debt VS Total AssetsCHKP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.2 Solvency

An Altman-Z score of 9.07 indicates that CHKP is not in any danger for bankruptcy at the moment.
CHKP has a Altman-Z score of 9.07. This is amongst the best in the industry. CHKP outperforms 83.21% of its industry peers.
There is no outstanding debt for CHKP. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 9.07
ROIC/WACC2.15
WACC8.96%
CHKP Yearly LT Debt VS Equity VS FCFCHKP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.3 Liquidity

CHKP has a Current Ratio of 1.19. This is a normal value and indicates that CHKP is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.19, CHKP is doing worse than 63.21% of the companies in the same industry.
CHKP has a Quick Ratio of 1.19. This is a normal value and indicates that CHKP is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of CHKP (1.19) is worse than 62.86% of its industry peers.
CHKP does not score too well on the current and quick ratio evaluation. However, as it has excellent solvency and profitability, these ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.19
Quick Ratio 1.19
CHKP Yearly Current Assets VS Current LiabilitesCHKP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

5

3. Growth

3.1 Past

CHKP shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 7.68%.
CHKP shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 8.26% yearly.
CHKP shows a small growth in Revenue. In the last year, the Revenue has grown by 6.27%.
CHKP shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.16% yearly.
EPS 1Y (TTM)7.68%
EPS 3Y9.12%
EPS 5Y8.26%
EPS Q2Q%9.22%
Revenue 1Y (TTM)6.27%
Revenue growth 3Y5.78%
Revenue growth 5Y5.16%
Sales Q2Q%6.02%

3.2 Future

CHKP is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.82% yearly.
CHKP is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.81% yearly.
EPS Next Y10.23%
EPS Next 2Y9.22%
EPS Next 3Y9.68%
EPS Next 5Y11.82%
Revenue Next Year6.2%
Revenue Next 2Y5.9%
Revenue Next 3Y5.86%
Revenue Next 5Y6.81%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CHKP Yearly Revenue VS EstimatesCHKP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 1B 2B 3B 4B
CHKP Yearly EPS VS EstimatesCHKP Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5 10 15 20

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 20.63 indicates a rather expensive valuation of CHKP.
CHKP's Price/Earnings ratio is a bit cheaper when compared to the industry. CHKP is cheaper than 75.71% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.20. CHKP is valued slightly cheaper when compared to this.
Based on the Price/Forward Earnings ratio of 18.00, the valuation of CHKP can be described as rather expensive.
Based on the Price/Forward Earnings ratio, CHKP is valued a bit cheaper than the industry average as 80.00% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 22.70. CHKP is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 20.63
Fwd PE 18
CHKP Price Earnings VS Forward Price EarningsCHKP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

CHKP's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. CHKP is cheaper than 81.79% of the companies in the same industry.
83.21% of the companies in the same industry are more expensive than CHKP, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 18.31
EV/EBITDA 19.53
CHKP Per share dataCHKP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CHKP does not grow enough to justify the current Price/Earnings ratio.
CHKP has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)2.02
PEG (5Y)2.5
EPS Next 2Y9.22%
EPS Next 3Y9.68%

0

5. Dividend

5.1 Amount

CHKP does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CHECK POINT SOFTWARE TECH

NASDAQ:CHKP (9/18/2025, 2:37:41 PM)

196.62

+0.08 (+0.04%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)07-30 2025-07-30/bmo
Earnings (Next)10-27 2025-10-27/bmo
Inst Owners70.34%
Inst Owner Change-1.59%
Ins Owners22.96%
Ins Owner ChangeN/A
Market Cap21.31B
Analysts73.04
Price Target227.36 (15.63%)
Short Float %3.89%
Short Ratio3.54
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-1.29%
Min EPS beat(2)-1.7%
Max EPS beat(2)-0.88%
EPS beat(4)0
Avg EPS beat(4)-1.21%
Min EPS beat(4)-1.99%
Max EPS beat(4)-0.28%
EPS beat(8)2
Avg EPS beat(8)-0.53%
EPS beat(12)6
Avg EPS beat(12)0.55%
EPS beat(16)9
Avg EPS beat(16)0.73%
Revenue beat(2)0
Avg Revenue beat(2)-1.57%
Min Revenue beat(2)-1.71%
Max Revenue beat(2)-1.44%
Revenue beat(4)0
Avg Revenue beat(4)-1.58%
Min Revenue beat(4)-1.92%
Max Revenue beat(4)-1.24%
Revenue beat(8)0
Avg Revenue beat(8)-1.47%
Revenue beat(12)0
Avg Revenue beat(12)-1.56%
Revenue beat(16)1
Avg Revenue beat(16)-1.23%
PT rev (1m)-1.35%
PT rev (3m)-5.57%
EPS NQ rev (1m)-0.11%
EPS NQ rev (3m)-0.6%
EPS NY rev (1m)0.07%
EPS NY rev (3m)-0.05%
Revenue NQ rev (1m)0.01%
Revenue NQ rev (3m)-0.14%
Revenue NY rev (1m)0.14%
Revenue NY rev (3m)0.07%
Valuation
Industry RankSector Rank
PE 20.63
Fwd PE 18
P/S 8.07
P/FCF 18.31
P/OCF 17.93
P/B 7.52
P/tB 24.05
EV/EBITDA 19.53
EPS(TTM)9.53
EY4.85%
EPS(NY)10.93
Fwd EY5.56%
FCF(TTM)10.74
FCFY5.46%
OCF(TTM)10.97
OCFY5.58%
SpS24.38
BVpS26.16
TBVpS8.17
PEG (NY)2.02
PEG (5Y)2.5
Profitability
Industry RankSector Rank
ROA 15.09%
ROE 30.27%
ROCE 22.21%
ROIC 19.22%
ROICexc 31.42%
ROICexgc 166.54%
OM 33%
PM (TTM) 32.48%
GM 86.92%
FCFM 44.06%
ROA(3y)14.46%
ROA(5y)14.34%
ROE(3y)29.1%
ROE(5y)27.36%
ROIC(3y)20.07%
ROIC(5y)19.43%
ROICexc(3y)33.25%
ROICexc(5y)32.25%
ROICexgc(3y)125.28%
ROICexgc(5y)97.86%
ROCE(3y)23.18%
ROCE(5y)22.45%
ROICexcg growth 3Y30.18%
ROICexcg growth 5Y26.49%
ROICexc growth 3Y-0.42%
ROICexc growth 5Y2.59%
OM growth 3Y-6.58%
OM growth 5Y-5.03%
PM growth 3Y-4.32%
PM growth 5Y-4.45%
GM growth 3Y-0.2%
GM growth 5Y-0.37%
F-Score7
Asset Turnover0.46
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 26.44%
Cap/Sales 0.94%
Interest Coverage 250
Cash Conversion 123.09%
Profit Quality 135.64%
Current Ratio 1.19
Quick Ratio 1.19
Altman-Z 9.07
F-Score7
WACC8.96%
ROIC/WACC2.15
Cap/Depr(3y)43.08%
Cap/Depr(5y)50.45%
Cap/Sales(3y)0.89%
Cap/Sales(5y)0.87%
Profit Quality(3y)125.99%
Profit Quality(5y)131.69%
High Growth Momentum
Growth
EPS 1Y (TTM)7.68%
EPS 3Y9.12%
EPS 5Y8.26%
EPS Q2Q%9.22%
EPS Next Y10.23%
EPS Next 2Y9.22%
EPS Next 3Y9.68%
EPS Next 5Y11.82%
Revenue 1Y (TTM)6.27%
Revenue growth 3Y5.78%
Revenue growth 5Y5.16%
Sales Q2Q%6.02%
Revenue Next Year6.2%
Revenue Next 2Y5.9%
Revenue Next 3Y5.86%
Revenue Next 5Y6.81%
EBIT growth 1Y-1.04%
EBIT growth 3Y-1.17%
EBIT growth 5Y-0.13%
EBIT Next Year5.55%
EBIT Next 3Y5.02%
EBIT Next 5Y5.86%
FCF growth 1Y0.42%
FCF growth 3Y-4.7%
FCF growth 5Y-0.95%
OCF growth 1Y0.95%
OCF growth 3Y-4.38%
OCF growth 5Y-0.96%